People: Robert S. Terzoli, Jr., Attorney

Photo of Robert S. Terzoli, Jr., Attorney

Robert S. Terzoli, Jr.

Attorney

Washington, D.C.
Direct: (202) 772-9725
0

Robert Terzoli is an attorney in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. 

Mr. Terzoli’s practice focuses primarily on trademark and patent, particularly Hatch-Waxman, litigation; as well as counseling and prosecution in the area of trademark law.  He has experience in the preparation, filing, and prosecution of trademark applications, performing searches, drafting clearance reports, as well as experience in enforcement, including both in court and out of court resolutions.

With respect to litigation, Mr. Terzoli has drafted dispositive motions, coordinated fact discovery, and assisted with depositions.  He has drafted sections of an appellate brief and has participated in several joint defense groups in the context of Hatch-Waxman ANDA matters.

Mr. Terzoli earned his J.D. from Georgetown University Law Center and a B.A. in History from UCLA.  He attended law school part-time while working full-time as a law clerk at Fanelli Haag PLLC, a leading intellectual property boutique law firm focused on issues facing the biotechnology, pharmaceutical, nanotechnology and chemical industries.  Previously, he was an Analyst at Arrowhead Research Corporation, a publicly-traded private equity firm focused on investments in the life sciences.  While at Arrowhead, he reported to the General Counsel and assisted on M&A and contentious employment law matters.  He also sourced and evaluated potential investment targets for management.

Robert Terzoli is an attorney in the Intellectual Property Department of Seyfarth Shaw LLP’s Washington, D.C. office. 

Mr. Terzoli’s practice focuses primarily on trademark and patent, particularly Hatch-Waxman, litigation; as well as counseling and prosecution in the area of trademark law.  He has experience in the preparation, filing, and prosecution of trademark applications, performing searches, drafting clearance reports, as well as experience in enforcement, including both in court and out of court resolutions.

With respect to litigation, Mr. Terzoli has drafted dispositive motions, coordinated fact discovery, and assisted with depositions.  He has drafted sections of an appellate brief and has participated in several joint defense groups in the context of Hatch-Waxman ANDA matters.

Mr. Terzoli earned his J.D. from Georgetown University Law Center and a B.A. in History from UCLA.  He attended law school part-time while working full-time as a law clerk at Fanelli Haag PLLC, a leading intellectual property boutique law firm focused on issues facing the biotechnology, pharmaceutical, nanotechnology and chemical industries.  Previously, he was an Analyst at Arrowhead Research Corporation, a publicly-traded private equity firm focused on investments in the life sciences.  While at Arrowhead, he reported to the General Counsel and assisted on M&A and contentious employment law matters.  He also sourced and evaluated potential investment targets for management.

Education

  • J.D., Georgetown University Law Center (2018)

  • B.A., University of California, Los Angeles

Admissions

  • California
  • Admitted in California only. Practice limited to matters before federal courts and federal agencies.

Publications

  • Co-Author, "Tribal Immunity Cannot Be Asserted to Escape IPR Proceedings," BioLoquitur, Seyfarth Shaw LLP (July 25, 2018)
  • Co-Author, "FDA Approves First Marijuana-Based Drug to Treat Epilepsy," BioLoquitur, Seyfarth Shaw LLP (July 5, 2018)
  • Co-Author, "An Illustrated Guide to the USPTO’s New Memo on Method of Treatment Claims," BioLoquitur, Seyfarth Shaw LLP (June 29, 2018)
  • Co-Author, "USPTO Announces Notice of Proposed Rulemaking for Claim Construction Standard used in PTAB Proceedings," BioLoquitur, Seyfarth Shaw LLP (May 8, 2018)
  • Co-Author, "Part 2 of 2: Supreme Court and Inter Partes Review," BioLoquitur, Seyfarth Shaw LLP (April 30, 2018)
  • Co-Author, "Part 1 of 2: Supreme Court and Inter Partes Review," BioLoquitur, Seyfarth Shaw LLP (April 30, 2018)
  • Co-Author, "Federal Circuit Opens Door for PTAB Institution Decision Appeals," BioLoquitur, Seyfarth Shaw LLP (January 23, 2018)
  • Co-Author, "No Longer the Stuff of Science Fiction: The FDA’s New Policy Approach to Regenerative Medicine Products," BioLoquitur, Seyfarth Shaw LLP (December 11, 2017)
  • Co-Author, "Shire v. Amneal – Compound Claim Not Obvious and API Supplier Not Liable Under FDA Safe Harbor," BioLoquitur, Seyfarth Shaw LLP (October 6, 2015)
  • Co-Author, "Patent Licensors Beware – No Challenge Clause Does Not Bar Challenge Before the PTAB," BioLoquitur, Seyfarth Shaw LLP (September 28, 2015)